Skip to main content
Terug
Watch Compare

Clene Inc.

Datakwaliteit: 100%
CLNN
NASDAQ Manufacturing Chemicals
€ 6,50
▲ € 0,15 (2,28%)
6 months return
—
Momentum
Neutral
5Y revenue growth
-27,48%

Groei

Revenue Growth (5Y)
-27,48%
Onder sectorgemiddelde (1,72%)
Revenue (1Y)-41,52%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROIC-127,72%
Net Margin-13086,50%
Op. Margin-11541,50%

Veiligheid

Debt / Equity
N/A
Current Ratio1,53
Interest Coverage-8,61

Waardering

PE (TTM|NTM)
-2,83 | -4,36
Onder sectorgemiddelde (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Revenue declined -27,48% annually over 5 years
Negative free cash flow of -18,59 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 14,04%

Price History

Financiële Trends

Koersdoel Analisten

6 analisten
Buy
+367.0%
upside to target
Huidig
€ 6,50
Consensus Target
€ 30,33
€ 20,00
Laag
€ 48,00
Hoog
Vooruitzicht
Forward K/W
-4,36
Forward WPA
-€ 1,46
Omzet Sch.
37,71 M

Winstverassingen

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -€ 0,66 · Rev Est: 33.830,0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -€ 0,50 -€ 0,88 -€ 0,61 -€ 0,78 — —
Estimate -€ 0,78 -€ 0,46 -€ 0,56 -€ 0,42 -€ 0,66 -€ 0,33
Verrassing +36,29% -91,13% -8,00% -85,38% — —

Growth

Rev 5Y: -27,48% · Earnings 1Y: N/A
Revenue Growth (1Y) -41,52% Revenue Growth (3Y) -44,70%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -27,48% Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: -13086,50%
Revenue (TTM) 200.000,0 Net Income (TTM) -26,17 M
ROE N/A ROA -117,80%
Gross Margin N/A Operating Margin -11541,50%
Net Margin -13086,50% Free Cash Flow (TTM) -18,59 M
ROIC -127,72% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 1,53
Debt / Equity N/A Current Ratio 1,53
Interest Coverage -8,61 Asset Turnover 0,01
Working Capital 4,37 M Tangible Book Value -12,36 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -2,83 · EV/EBITDA: N/A
P/E Ratio -2,83 Forward P/E -4,36
P/B Ratio N/A P/S Ratio 370,43
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 1,96 Fwd Earnings Yield N/A
FCF Yield -25,09%
Market Cap 74,09 M Enterprise Value 84,04 M

Per Share

EPS: N/A · FCF/Share: -1,58
EPS (Diluted TTM) N/A Revenue / Share 0,02
FCF / Share -1,58 OCF / Share -1,57
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 71,01% · CapEx/Rev: 19,50%
CapEx / Revenue 19,50% FCF Conversion 71,01%
SBC-Adj. FCF -25,79 M Growth Momentum -14,04

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 200.000,0 342.000,0 654.000,0 473.000,0 723.000,0
Net Income -26,17 M -39,40 M -49,50 M -29,92 M -9,74 M
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -23,08 M -33,09 M -40,54 M -48,41 M -49,98 M
EBITDA — — — — —
R&D Expenses 14,01 M 20,06 M 26,66 M 31,92 M 28,42 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 2,68 M 4,06 M 4,56 M -3,30 M 870.000,0
Income Tax 0,0 0,0 0,0 0,0 -428.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 18,13 M 27,34 M 52,34 M 44,49 M 63,06 M
Total Liabilities 35,72 M 36,19 M 38,95 M 41,26 M 50,47 M
Shareholders' Equity -17,59 M -8,86 M 13,39 M 3,24 M 12,60 M
Total Debt 17,79 M — — — —
Cash & Equivalents 5,19 M 12,16 M 28,82 M 18,33 M 50,35 M
Current Assets 8,98 M 16,16 M 38,85 M 29,20 M 54,58 M
Current Liabilities 10,78 M 10,29 M 25,33 M 13,86 M 6,03 M

Sectorvergelijking

vs Manufacturing sector mediaan (1605 peers)
Metriek Aandeel Sector Mediaan
P/E -2,8 -1,5
P/B — 1,6
ROE % — -54,7
Net Margin % -13086,5 -41,5
Rev Growth 5Y % -27,5 1,7
D/E — 0,3